Literature DB >> 19655095

Protein kinase D1, a new molecular player in VEGF signaling and angiogenesis.

Chang Hoon Ha1, Zheng Gen Jin.   

Abstract

Vascular endothelial growth factor (VEGF) is essential for many angiogenic processes both in normal and pathological conditions. However, the signaling pathways involved in VEGF-induced angiogenesis are incompletely understood. The protein kinase D1 (PKD1), a newly described calcium/calmodulin-dependent serine/threonine kinase, has been implicated in cell migration, proliferation and membrane trafficking. Increasing evidence suggests critical roles for PKD1-mediated signaling pathways in endothelial cells, particularly in the regulation of VEGF-induced angiogenesis. Recent studies show that class IIa histone deacetylases (HDACs) are PKD1 substrates and VEGF signal-responsive repressors of myocyte enhancer factor-2 (MEF2) transcriptional activation in endothelial cells. This review provides a guide to PKD1 signaling pathways and the direct downstream targets of PKD1 in VEGF signaling, and suggests important functions of PKD1 in angiogenesis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19655095      PMCID: PMC4228936          DOI: 10.1007/s10059-009-0109-9

Source DB:  PubMed          Journal:  Mol Cells        ISSN: 1016-8478            Impact factor:   5.034


  91 in total

1.  Identification of a new endothelial cell growth factor receptor tyrosine kinase.

Authors:  B I Terman; M E Carrion; E Kovacs; B A Rasmussen; R L Eddy; T B Shows
Journal:  Oncogene       Date:  1991-09       Impact factor: 9.867

2.  Nucleotide sequence and expression of a novel human receptor-type tyrosine kinase gene (flt) closely related to the fms family.

Authors:  M Shibuya; S Yamaguchi; A Yamane; T Ikeda; A Tojo; H Matsushime; M Sato
Journal:  Oncogene       Date:  1990-04       Impact factor: 9.867

3.  Protein kinase C nu/protein kinase D3 nuclear localization, catalytic activation, and intracellular redistribution in response to G protein-coupled receptor agonists.

Authors:  Osvaldo Rey; Jingzhen Yuan; Steven H Young; Enrique Rozengurt
Journal:  J Biol Chem       Date:  2003-04-03       Impact factor: 5.157

4.  PKCu is a novel, atypical member of the protein kinase C family.

Authors:  F J Johannes; J Prestle; S Eis; P Oberhagemann; K Pfizenmaier
Journal:  J Biol Chem       Date:  1994-02-25       Impact factor: 5.157

5.  The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing.

Authors:  E Tischer; R Mitchell; T Hartman; M Silva; D Gospodarowicz; J C Fiddes; J A Abraham
Journal:  J Biol Chem       Date:  1991-06-25       Impact factor: 5.157

6.  G protein-coupled receptor-mediated phosphorylation of the activation loop of protein kinase D: dependence on plasma membrane translocation and protein kinase Cepsilon.

Authors:  Osvaldo Rey; Joseph R Reeve; Elena Zhukova; James Sinnett-Smith; Enrique Rozengurt
Journal:  J Biol Chem       Date:  2004-06-08       Impact factor: 5.157

7.  The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing of RNA.

Authors:  K A Houck; N Ferrara; J Winer; G Cachianes; B Li; D W Leung
Journal:  Mol Endocrinol       Date:  1991-12

8.  Protein kinase D regulates basolateral membrane protein exit from trans-Golgi network.

Authors:  Charles Yeaman; M Inmaculada Ayala; Jessica R Wright; Frederic Bard; Carine Bossard; Agnes Ang; Yusuke Maeda; Thomas Seufferlein; Ira Mellman; W James Nelson; Vivek Malhotra
Journal:  Nat Cell Biol       Date:  2004-01-25       Impact factor: 28.824

9.  Molecular cloning and characterization of protein kinase D: a target for diacylglycerol and phorbol esters with a distinctive catalytic domain.

Authors:  A M Valverde; J Sinnett-Smith; J Van Lint; E Rozengurt
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-30       Impact factor: 11.205

Review 10.  VEGF signalling: integration and multi-tasking in endothelial cell biology.

Authors:  I Zachary
Journal:  Biochem Soc Trans       Date:  2003-12       Impact factor: 5.407

View more
  12 in total

1.  Adrenergic signaling controls RGK-dependent trafficking of cardiac voltage-gated L-type Ca2+ channels through PKD1.

Authors:  Bong Sook Jhun; Jin O-Uchi; Coeli M B Lopes; Zheng Gen Jin; Weiye Wang; Chang Hoon Ha; Jinjing Zhao; Ji Young Kim; Chelsea Wong; Robert T Dirksen
Journal:  Circ Res       Date:  2011-11-10       Impact factor: 17.367

Review 2.  Protein kinase D as a potential new target for cancer therapy.

Authors:  Courtney R LaValle; Kara M George; Elizabeth R Sharlow; John S Lazo; Peter Wipf; Q Jane Wang
Journal:  Biochim Biophys Acta       Date:  2010-05-24

Review 3.  What model organisms and interactomics can reveal about the genetics of human obesity.

Authors:  Michael J Williams; Markus S Almén; Robert Fredriksson; Helgi B Schiöth
Journal:  Cell Mol Life Sci       Date:  2012-05-23       Impact factor: 9.261

4.  Synthesis and Structure-Activity Relationships of Benzothienothiazepinone Inhibitors of Protein Kinase D.

Authors:  Karla Bravo-Altamirano; Kara M George; Marie-Céline Frantz; Courtney R Lavalle; Manuj Tandon; Stephanie Leimgruber; Elizabeth R Sharlow; John S Lazo; Q Jane Wang; Peter Wipf
Journal:  ACS Med Chem Lett       Date:  2011-02-14       Impact factor: 4.345

Review 5.  Vascular precursor cells in tissue injury repair.

Authors:  Xin Shi; Weihong Zhang; Liya Yin; William M Chilian; Jessica Krieger; Ping Zhang
Journal:  Transl Res       Date:  2017-02-21       Impact factor: 7.012

6.  LPA/PKD-1-FoxO1 Signaling Axis Mediates Endothelial Cell CD36 Transcriptional Repression and Proangiogenic and Proarteriogenic Reprogramming.

Authors:  Bin Ren; Brad Best; Devi Prasadh Ramakrishnan; Brian P Walcott; Peter Storz; Roy L Silverstein
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-03-24       Impact factor: 8.311

7.  Protein Kinase D: A Potential Therapeutic Target in Prostate Cancer.

Authors:  Adhiraj Roy; Q Jane Wang
Journal:  Mol Cell Pharmacol       Date:  2017

8.  Design, Synthesis, and Biological Evaluation of PKD Inhibitors.

Authors:  Kara M George; Marie-Céline Frantz; Karla Bravo-Altamirano; Courtney R Lavalle; Manuj Tandon; Stephanie Leimgruber; Elizabeth R Sharlow; John S Lazo; Q Jane Wang; Peter Wipf
Journal:  Pharmaceutics       Date:  2011       Impact factor: 6.321

9.  VEGF and Angiopoietin-1 exert opposing effects on cell junctions by regulating the Rho GEF Syx.

Authors:  Siu P Ngok; Rory Geyer; Miaoliang Liu; Antonis Kourtidis; Sudesh Agrawal; Chuanshen Wu; Himabindu Reddy Seerapu; Laura J Lewis-Tuffin; Karen L Moodie; Deborah Huveldt; Ruth Marx; Jay M Baraban; Peter Storz; Arie Horowitz; Panos Z Anastasiadis
Journal:  J Cell Biol       Date:  2012-12-17       Impact factor: 10.539

10.  Discovery of a potent protein kinase D inhibitor: insights in the binding mode of pyrazolo[3,4-d]pyrimidine analogues.

Authors:  Klaas Verschueren; Mathias Cobbaut; Joachim Demaerel; Lina Saadah; Arnout R D Voet; Johan Van Lint; Wim M De Borggraeve
Journal:  Medchemcomm       Date:  2017-02-09       Impact factor: 3.597

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.